Cetera Trust Company’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.53M Buy
3,961
+160
+4% +$59.3K 0.77% 35
2026
Q1
$1.11M Buy
3,801
+25
+0.7% +$8.22K 0.63% 45
2025
Q4
$1.32M Sell
3,776
-480
-11% -$162K 0.71% 37
2025
Q3
$1.38M Buy
4,256
+75
+2% +$23.3K 0.77% 38
2025
Q2
$1.63M Buy
4,181
+80
+2% +$32.2K 0.97% 33
2025
Q1
$1.78M Buy
4,101
+140
+4% +$56.2K 1.14% 27
2024
Q4
$1.46M Sell
3,961
-725
-15% -$303K 0.95% 32
2024
Q3
$2.44M Sell
4,686
-120
-2% -$64.1K 1.49% 19
2024
Q2
$2.6M Sell
4,806
-661
-12% -$349K 1.63% 14
2024
Q1
$2.83M Sell
5,467
-125
-2% -$62.2K 1.71% 17
2023
Q4
$2.64M Buy
+5,592
New +$2.59M 1.64% 16

Other funds holding ELV

Cetera Trust Company's ELV Position: Q2 2026 in Review

Cetera Trust Company increased its Elevance Health (ELV) stake by 4.2% in Q2 2026, buying an estimated $59.3K and bringing the position to 3,961 shares worth $1.53M. The position accounts for 0.77% of the portfolio, ranked #35.

Cetera Trust Company first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.83M in Q1 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Cetera Trust Company held 3,961 shares of Elevance Health worth $1.53M as of Q2 2026.
  • Cetera Trust Company bought 160 Elevance Health shares in Q2 2026, an estimated $59.3K.
  • Elevance Health made up 0.77% of Cetera Trust Company's portfolio in Q2 2026, its #35 holding.
  • Cetera Trust Company first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • Cetera Trust Company's Elevance Health position peaked at $2.83M in Q1 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Cetera Trust Company's 13F filing for Q2 2026, filed 13 Aug 2026.